Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Law
Certificates Of Confidentiality: Protecting Human Subject Research Data In Law And Practice, Leslie E. Wolf, Mayank J. Patel, Brett A. Tarver, Jeffrey L. Austin, Lauren A. Dame, Laura M. Beskow
Certificates Of Confidentiality: Protecting Human Subject Research Data In Law And Practice, Leslie E. Wolf, Mayank J. Patel, Brett A. Tarver, Jeffrey L. Austin, Lauren A. Dame, Laura M. Beskow
Leslie E. Wolf
Researchers often require and collect sensitive information about individuals to answer important scientific questions that impact individual health and well-being and the public health. Researchers recognize they have a duty to maintain the confidentiality of the data they collect and typically make promises, which are documented in the consent form. The legal interests of others, however, can threaten researchers’ promises of confidentiality, if they seek access to the data through subpoena. Certificates of Confidentiality (Certificates), authorized by federal statute, are an important tool for protecting individually identifiable sensitive research data from compelled disclosure. However, questions persist in the research community …
Book Review, Behind Closed Doors: Irbs And The Making Of Ethical Research, Leslie E. Wolf
Book Review, Behind Closed Doors: Irbs And The Making Of Ethical Research, Leslie E. Wolf
Leslie E. Wolf
No abstract provided.
A New Era In The Ethics Of Human Embryonic Stem Cell Research, Bernard Lo, Patricia Zettler, Marcelle I. Cedars, E. Gates, Arnold R. Kriegstein, Michelle Oberman, Renee R. Pera, Richard M. Wagner, Mary T. Wuerth, Leslie E. Wolf, Keith R. Yamamoto
A New Era In The Ethics Of Human Embryonic Stem Cell Research, Bernard Lo, Patricia Zettler, Marcelle I. Cedars, E. Gates, Arnold R. Kriegstein, Michelle Oberman, Renee R. Pera, Richard M. Wagner, Mary T. Wuerth, Leslie E. Wolf, Keith R. Yamamoto
Leslie E. Wolf
Scientific progress in human embryonic stem cell (hESC) research and increased funding make it imperative to look ahead to the ethical issues generated by the expected use of hESCs for transplantation. Several issues should be addressed now, even though phase I clinical trials of hESC transplantation are still in the future. To minimize the risk of hESC transplantation, donors of materials used to derive hESC lines will need to be recontacted to update their medical history and screening. Because of privacy concerns, such recontact needs to be discussed and agreed to at the time of donation, before new hESC lines …